Literature DB >> 8804261

Emerging problems in prion disease.

V Dodelet, M Ricketts, N R Cashman.   

Abstract

The authors comment on the report by Drs. Chris MacKnight and Kenneth Rockwood (see pages 529 to 536 of this issue) on the implications for Canadian physicians of human prion diseases. They argue that there is reason for concern about the possible crossover of bovine spongiform encephalopathy to humans in the form of a variant of Creutzfeldt-Jakob disease (CJD) recently identified in the United Kingdom. A second emerging issue is the potential for the causative agent of CJD to be transmitted through donated blood and tissue. Although the epidemiologic evidence suggests that this risk is remote, current national and international initiatives to increase surveillance for new cases of CJD are timely.

Entities:  

Mesh:

Year:  1996        PMID: 8804261      PMCID: PMC1335034     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  7 in total

1.  Cellular isoform of the scrapie agent protein participates in lymphocyte activation.

Authors:  N R Cashman; R Loertscher; J Nalbantoglu; I Shaw; R J Kascsak; D C Bolton; P E Bendheim
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

2.  Fibrils from brains of cows with new cattle disease contain scrapie-associated protein.

Authors:  J Hope; L J Reekie; N Hunter; G Multhaup; K Beyreuther; H White; A C Scott; M J Stack; M Dawson; G A Wells
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  BSE transmission to macaques.

Authors:  C I Lasmézas; J P Deslys; R Demaimay; K T Adjou; F Lamoury; D Dormont; O Robain; J Ironside; J J Hauw
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy.

Authors:  P Brown; D C Gajdusek; C J Gibbs; D M Asher
Journal:  N Engl J Med       Date:  1985-09-19       Impact factor: 91.245

5.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

6.  Creutzfeldt-Jakob disease and blood transfusion.

Authors:  T F Esmonde; R G Will; J M Slattery; R Knight; R Harries-Jones; R de Silva; W B Matthews
Journal:  Lancet       Date:  1993-01-23       Impact factor: 79.321

7.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

  7 in total
  2 in total

1.  The quandary of Creutzfeldt-Jakob disease.

Authors:  B Larke
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

Review 2.  Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: integrating science, legal duties and ethical mandates.

Authors:  T Caulfield; J Dossetor; L Boshkov; J Hannon; D Sawyer; G Robertson
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.